Nordion (SHC) - Long-Term Debt to Capital Ratio

Corporate emblem and logo of Sotera Health Company (SHC)

Sotera Health Company (SHC) operates an international network of medical technology decontamination centers that ensure global healthcare safety through unique technologies. This price chart illustrates the price action of Sotera Health Company (SHC), where the long-term debt-to-equity ratio stands at 3.54. Stable cash flows are supported by industry demand for sterilization, despite stringent environmental regulations. A broad range of services and a global client base minimize risks.

Nordion (SHC): Long-Term Debt to Equity from 07/04/2022 to 10/31/2026
Core merchandise of soterahealth.com

For Sotera Health Company (SHC), which develops capital-intensive gamma sterilization systems, the share of long-term liabilities in capital reflects the cost of infrastructure expansion under FDA supervision. The ratio is calculated as the proportion of loans with maturities exceeding one year to equity, allowing investors to assess the debt load and the sustainability of financial leverage while scaling high-margin operational capacities.

Analysis of competing companies

Long-Term Liabilities to Capital Agilent Technologies, Inc. A|Long-Term Debt to Capital DGX|Illumina Platform - Long-Term Debt to Capital Ratio|Long-Term Debt to Capital EXAS (Exact Sciences)|Long-Term Debt to Capital revvity.com RVTY|BIO - Long-Term Debt to Equity|NNNN (Anbio Biotechnology Ltd) - Long-Term Debt to Capital Ratio|QDEL: Long-Term Debt to Capital|OPKO Health Corp. (OPK) - Long-Term Debt to Capital|Long-Term Debt to Equity CareDx Inc|Long-Term Debt to Equity MRVI|Long-Term Debt to Equity Ratio FLGT (Fulgent Genetics)|LAB - Long-Term Liabilities to Capital|Long-Term Debt to Equity Cytek Bio CTKB|Ratio of Long-Term Indebtedness to Capital OraSure Corp (OSUR)|Exagen Diagnostics - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital mdxhealth.com MDXH|Lucid Diagnostics (LUCD) - Long-Term Debt to Equity|PRE - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Insight Molecular Diagnostics, Inc.|Trinity Biotech Corp (TRIB) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity ProPhase Labs, Inc. (PRPH)|AIMD - Long-Term Liabilities to Capital|Co-Diagnostics - Long-Term Debt to Equity Ratio|Long-Term Loans to Capital Ratio HSCS (Heart Test Laboratories, Inc.)|Biomerica, Inc - Long-Term Debt to Capital|Long-Term Liabilities to Capital Cardio Diagnostics|Virax Biolabs Group (VRAX) - Long-Term Debt to Equity|bluejaydx.com - Long-Term Debt to Capital Coefficient|AWH (Aspira Women's Health Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital Accelerate Diagnostics Inc.|Long-Term Debt to Equity Ratio CNTG (CENTOGENE, N.V.)|ENZ (enzo.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital FRES (Fresh2 Group)|Long-Term Debt to Capital Coefficient GENE|23andMe - Long-Term Debt to Capital|Long-Term Liabilities to Capital Psychemedics Corp.